US 12138272
Methods and compositions for treating amyotrophic lateral sclerosis
granted A61KA61K31/192A61K31/575
Quick answer
US patent 12138272 (Methods and compositions for treating amyotrophic lateral sclerosis) held by Amylyx Pharmaceuticals, Inc. expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Amylyx Pharmaceuticals, Inc.
- Grant date
- Tue Nov 12 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/192, A61K31/575, A61K38/13, A61P